Skip to main content
DNA Labs India

SEC23B Gene Anemia dyserythropoietic type 2 NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

SEC23B Gene Anemia dyserythropoietic type 2 NGS Genetic Test

Short Name: SEC23B Gene Test for CDA Type II

Also known as: Congenital Dyserythropoietic Anemia Type II, CDA Type II, Hereditary Dyserythropoietic Anemia

SEC23B Gene Anemia dyserythropoietic type 2 NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing (NGS) on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in 3 to 4 Weeks. Free home collection in 300+ cities across India.

NGS Genetic Test🏠 Home Collection

🩺 Medically Reviewed By

Overview

To accurately detect mutations in the SEC23B gene for definitive diagnosis of Anemia Dyserythropoietic Type 2 (CDA Type II), aiding in clinical management, genetic counseling, and family screening.

Test Code
1890
Price
₹20,000
Sample Type
Blood or Extracted DNA or One drop Blood on FTA Card
Result Time
3 to 4 Weeks
Fasting Required
No
Method
Next-Generation Sequencing (NGS)
Step 1

Sample Collection

No special preparation required. Ensure genetic counseling is provided if indicated.

Method: Venipuncture or finger-prick for FTA card

Step 2

Laboratory Analysis

Standard venipuncture or finger-prick for FTA card collection following aseptic techniques.

Step 3

Report Delivery

Label sample properly and transport at ambient temperature to the laboratory.

Timeline: 3 to 4 Weeks

Patient Instructions

1
Before the Test:Genetic counseling recommended to discuss implications, benefits, and limitations of testing.
2
During the Test:Sample collection via blood draw or FTA card; procedure is minimally invasive.
3
After the Test:Await results; follow-up with healthcare provider for interpretation and management planning.

About This Test

Who Should Get This Test

To accurately detect mutations in the SEC23B gene for definitive diagnosis of Anemia Dyserythropoietic Type 2 (CDA Type II), aiding in clinical management, genetic counseling, and family screening.

How to Prepare

  • Verify patient identity and consent
  • Use appropriate collection tubes or FTA cards
  • Avoid hemolysis during blood draw
  • Store sample at room temperature until shipment

Doctor's Notes

Reviewed by — MBBS, MD (Medical Genetics) · Reg. No. 8532

"Early genetic testing with SEC23B analysis is critical for confirming CDA Type II, guiding management to prevent complications like iron overload, and facilitating family counseling."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One drop Blood on FTA Card
Sample Volume3-5 mL blood or equivalent DNA
ContainerEDTA tube or FTA card
Collection MethodVenipuncture or finger-prick for FTA card

Sample Stability

Blood in EDTA: stable for 7 days at room temperature
FTA card: stable for months if stored dry
Sample Rejection Criteria:
  • Insufficient sample volume
  • Hemolyzed or clotted sample
  • Improper labeling or missing information

Understanding Your Results

Results from the SEC23B gene NGS test indicate the presence or absence of genetic variants associated with Anemia Dyserythropoietic Type 2. Interpretation should be correlated with clinical findings and family history.
📊

No pathogenic variants detected

Negative for SEC23B mutations; CDA Type II unlikely but not excluded if clinical suspicion high.

📊

Pathogenic or likely pathogenic variant detected

Confirms diagnosis of CDA Type II; enables targeted management and genetic counseling.

📊

Variant of uncertain significance (VUS) detected

Further testing or family studies may be required; consult genetic specialist for guidance.

⚠️ When to Consult a Doctor:

If experiencing symptoms of chronic anemia, unexplained fatigue, or have a family history of CDA Type II, consult a hematologist or geneticist for evaluation and possible testing.

Limitations

  • May not detect all types of mutations (e.g., large deletions/duplications)
  • Results may include variants of uncertain significance (VUS)
  • Does not replace comprehensive clinical evaluation

Risks & Considerations

  • Minimal physical risks from blood draw
  • Potential psychological impact of genetic results
  • Risk of identifying variants of uncertain significance requiring further investigation

Interfering Factors

  • Sample contamination or degradation
  • Recent blood transfusions affecting DNA purity
  • Technical errors during sequencing or analysis

Compare With Similar Tests

TestSEC23B Gene Anemia dyserythropoietic type 2 NGS Genetic TestComplete Blood Count (CBC)Peripheral Blood SmearIron StudiesSanger Sequencing of SEC23B
ComparisonSEC23B Gene Anemia dyserythropoietic type 2 NGS Genetic TestProvides initial anemia detection but lacks genetic specificity.Shows red cell abnormalities but cannot confirm genetic etiology.Assesses iron status but not specific to CDA Type II.Targeted but less comprehensive than NGS for mutation detection.

Frequently Asked Questions

What is Anemia Dyserythropoietic Type 2?
It is a rare inherited blood disorder caused by mutations in the SEC23B gene, leading to abnormal red blood cell production and chronic anemia.
How is the SEC23B Gene Test performed?
The test uses Next-Generation Sequencing (NGS) to analyze the DNA sequence of the SEC23B gene from a blood or DNA sample, identifying mutations.
What is the cost of this genetic test in India?
The test costs INR 20,000 at DNA Labs India, with potential discounts and free home sample collection.
Is home sample collection available?
Yes, DNA Labs India offers free home sample collection for this test across many cities in India.
How long does it take to get the results?
Results are typically available within 3 to 4 weeks after sample receipt.
What sample type is required?
Blood, extracted DNA, or a drop of blood on an FTA card can be used.
Are there any preparation steps before the test?
No special preparation like fasting is required, but genetic counseling is advised.
What do the results indicate?
Results show if pathogenic variants in the SEC23B gene are present, helping confirm or rule out CDA Type II.
Is the test accurate?
Yes, NGS is a highly accurate method for detecting mutations in the SEC23B gene, but it may not identify all mutation types.
Can this test be used for prenatal diagnosis?
Prenatal testing may be possible with appropriate genetic counseling and sample collection, but consult a specialist.
What should I do if a variant of uncertain significance is found?
Further evaluation, including family studies or additional testing, may be recommended; discuss with a genetic counselor.
Is this test covered by insurance?
Coverage varies; it is often not covered by government schemes, but private insurance may have specific terms. Check with your provider.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.